Polyrizon Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Polyrizon Ltd
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Polyrizon Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Polyrizon Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Polyrizon Ltd is PLRZ:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Polyrizon Ltd has its primary listing on NASDAQ (Small cap). You can trade Polyrizon Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Polyrizon Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Polyrizon Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Polyrizon Ltd.